Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Glioma 2Uterine Cervical Dysplasia 1Sarcoma, Kaposi 1Multiple Myeloma 1Lymphopenia 1Lymphoma, Non-Hodgkin 1HIV Infections 1Gliosarcoma 1Glioblastoma 1AIDS-related Kaposi sarcoma 1

Interventions

pembrolizumab 3Nivolumab 3Valganciclovir 2Filgrastim 2Etoposide 2Docetaxel 2valspodar 1talimogene laherparepvec 1liposomal doxorubicin 1lenvatinib 1fialuridine 1etoposide phosphate 1efineptakin alfa 1X-Rays 1Thalidomide 1Sunitinib 1Specimen Handling 1SUB1 protein, human 1Ritonavir 1Propranolol 1Peripheral Blood Stem Cell Transplantation 1Nevirapine 1Nelfinavir 1Maraviroc 1Magnetic Resonance Spectroscopy 1Lopinavir 1Indinavir 1Ifosfamide 1Gemcitabine 1Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sarcoma, Kaposi × efineptakin alfa × Clear all
NCT04893018 2024-06-27

NT-I7 for Kaposi Sarcoma in Patients With or Without HIV

Fred Hutchinson Cancer Center

Phase 1 Terminated
8 enrolled 14 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡